Loading quotes, fundamentals, and earnings… This usually takes a few seconds.
Abbott Laboratories
ABT
Preparing chart…
Chart by TradingView — for analysis only.
Key Statistics
Earnings
Quarterly Results
ABT
Preparing chart…
Chart by TradingView — for analysis only.
Key Statistics
Earnings
Quarterly Results
ABT
$101.56
+0.50% (+$0.51)
Chart by TradingView — for analysis only.
Key Statistics
Market Cap
—
P/E Ratio
—
Forward P/E
—
EPS
—
Dividend Yield
—
52W High
$139.06
52W Low
$99.05
Avg Volume
9.6M
Healthcare
Medical Devices
Some fundamental metrics are unavailable; 52-week range and average volume may still come from live quotes.
Abbott Laboratories is a diversified global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of health care products worldwide. It operates across four key segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, addressing needs from chronic disease management to acute diagnostics. The company offers generic pharmaceuticals treating conditions such as pancreatic exocrine insufficiency, irritable bowel syndrome, dyslipidemia, hypertension, hypothyroidism, pain, fever, inflammation, and migraine, alongside anti-infectives, influenza vaccines, and gastrointestinal regulators. Notable products include cardiovascular devices like pacemakers and stents, diabetes management tools such as continuous glucose monitors, pediatric and adult nutritional formulas, and advanced diagnostic equipment like immunoassays and point-of-care testing kits. With approximately 114,000 employees and a history dating back to 1888, Abbott Laboratories generates the majority of its sales outside the United States, playing a pivotal role in advancing medical innovation, improving patient outcomes, and supporting global health initiatives through its extensive reach in consumer, institutional, and professional markets.
Company website →Earnings
Quarterly Results
| Quarter | Revenue | EPS |
|---|---|---|
| 2026-01-22 | — | $1.50 |
| 2025-10-15 | — | $1.30 |
| 2025-07-17 | — | $1.26 |
| 2025-04-16 | — | $1.09 |
Related Tools
Plan and size trades
Free calculators on the site — same tools linked from the home page. Not financial advice.
How many shares to buy for your risk budget.
See if a setup meets your minimum R:R.
Estimate dollar P/L before you enter.
Quick valuation check from price and EPS.
Rough fair value from cash-flow assumptions.
Breadth, indices, and context at a glance.
Abbott Laboratories is a diversified global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of health care products worldwide. It operates across four key segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, addressing needs from chronic disease management to acute diagnostics. The company offers generic pharmaceuticals treating conditions such as pancreatic exocrine insufficiency, irritable bowel syndrome, dyslipidemia, hypertension, hypothyroidism, pain, fever, inflammation, and migraine, alongside anti-infectives, influenza vaccines, and gastrointestinal regulators. Notable products include cardiovascular devices like pacemakers and stents, diabetes management tools such as continuous glucose monitors, pediatric and adult nutritional formulas, and advanced diagnostic equipment like immunoassays and point-of-care testing kits. With approximately 114,000 employees and a history dating back to 1888, Abbott Laboratories generates the majority of its sales outside the United States, playing a pivotal role in advancing medical innovation, improving patient outcomes, and supporting global health initiatives through its extensive reach in consumer, institutional, and professional markets.